Sector revisions Cipla Limited

Stocks

Delayed NSE India S.E. 09:43:22 19/08/2026 +04			5-day change	1st Jan Change
1,426.80 ^INR	-0.30%		-2.54%	-5.66%

08-11	Global drugmakers invest billions to boost US presence	RE
07-28	Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
CIPLA LIMITED					36
SUN PHARMACEUTICAL INDUSTRIES LTD.					33
OTSUKA HOLDINGS CO., LTD.					12
ZYDUS LIFESCIENCES LIMITED					30
KRKA, D. D.					6
GEDEON RICHTER					7
ONO PHARMACEUTICAL CO., LTD.					12
GLENMARK PHARMACEUTICALS LIMITED					11
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.				-	-
AJANTA PHARMA LIMITED					14
SIMCERE PHARMACEUTICAL GROUP LIMITED					4
ASPEN PHARMACARE HOLDINGS LIMITED					4
ASTRA INDUSTRIAL GROUP COMPANY				-	1
SUNSHINE LAKE PHARMA CO., LTD.	-	-		-	-
HAW PAR CORPORATION LIMITED		-	-	-	1
JAMJOOM PHARMACEUTICALS FACTORY COMPANY					3
APICHOPE PHARMACEUTICAL GROUP CO., LTD.				-	-
CAREGEN CO., LTD.				-	-
Average					12
Weighted average by Cap.					20